Position in TRVI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$246,594,552
+$88,853,372 QoQ
Shares Held
13,222,228
0.0% QoQ
Ownership
9.28%
of shares outstanding
% of Portfolio
15.53%
of 13F equity value
Holder Rank
#1
of 216 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NEA Management Company, LLC holds $1,505,317,406 across 24 Biotechnology names. TRVI ranks #1 (16.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TRVI |
Trevi Therapeutics, Inc.
This page
|
13,222,228 | $246,594,552 | |
| 2 | MBX |
MBX Biosciences, Inc.
|
3,614,486 | $199,519,627 | |
| 3 | GLUE |
Monte Rosa Therapeutics, Inc.
|
7,692,298 | $186,153,611 | |
| 4 | CELC |
Celcuity Inc.
|
1,710,561 | $178,958,891 | |
| 5 | SGP |
SpyGlass Pharma, Inc.
|
7,392,301 | $164,552,620 | |
| 6 | SVRA |
Savara Inc
|
24,471,264 | $150,742,986 | |
| 7 | ZBIO |
Zenas BioPharma, Inc.
|
4,023,219 | $102,109,298 | |
| 8 | AUPH |
Aurinia Pharmaceuticals Inc.
|
3,969,834 | $67,368,082 |
All Filings in TRVI
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $246,594,552 | 13,222,228 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $157,741,180 | 13,222,228 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $165,542,294 | 13,222,228 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $120,983,386 | 13,222,228 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $72,325,587 | 13,222,228 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $71,519,665 | 11,370,376 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $46,845,949 | 11,370,376 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $37,977,055 | 11,370,376 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $33,883,720 | 11,370,376 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $39,227,797 | 11,370,376 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $15,236,303 | 11,370,376 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $24,787,419 | 11,370,376 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $27,175,198 | 11,370,376 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $21,035,195 | 11,370,376 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $21,950,225 | 11,373,174 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $17,514,687 | 11,373,174 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $31,958,618 | 11,373,174 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $6,155 | 2,798 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,645,702 | 5,940,796 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,317,114 | 5,940,796 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $13,366,791 | 5,940,796 | Shares | Defined | 2021-08-02 | |
| 2021-03-31 | $16,099,557 | 5,940,796 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $14,376,726 | 5,940,796 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $23,941,407 | 5,940,796 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $39,090,437 | 5,940,796 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $14,612,074 | 4,441,360 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||